Search Results 491-500 of 14755 for anti-TNF drugs
An experimental drug for Alzheimer's disease shows promise to slow the progression of the diseas. A Mayo Clinic Neurologist gives perspective.
Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aplisol; Tubersol. Descriptions. Tuberculin ...
This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...
17 edition of Oncotarget. “We were surprised to observe that when morbidly obese mice were treated with certain cancer-fighting drugs, the drugs not only ...
Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Tobradex; Tobradex ST. Canadian Brand Name.
About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Thyrotropin alfa injection is a form of human thyroid ...
A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.